By Professor David Thomas

Journal articles

Thomas DM; Dowgiert J; Geddes TJ; Francescutti-Verbeem D; Liu X; Kuhn DM, 2004, 'Microglial activation is a pharmacologically specific marker for the neurotoxic amphetamines.', Neurosci Lett, 367, pp. 349 - 354, http://dx.doi.org/10.1016/j.neulet.2004.06.065

Thomas DM; Fleming NI; Holloway AJ; Bowtell DDL, 2004, 'Molecular medicine: A clinician's primer on microarrays', Internal Medicine Journal, 34, pp. 565 - 569, http://dx.doi.org/10.1111/j.1445-5994.2004.00680.x

Dudley AC; Thomas D; Best J; Jenkins A, 2004, 'The STATs in cell stress-type responses', Cell Communication and Signaling, 2, http://dx.doi.org/10.1186/1478-811X-2-8

Thomas DM; Francescutti-Verbeem DM; Liu X; Kuhn DM, 2004, 'Identification of differentially regulated transcripts in mouse striatum following methamphetamine treatment--an oligonucleotide microarray approach.', J Neurochem, 88, pp. 380 - 393, http://dx.doi.org/10.1046/j.1471-4159.2003.02182.x

Thomas DM; Walker PD; Benjamins JA; Geddes TJ; Kuhn DM, 2004, 'Methamphetamine neurotoxicity in dopamine nerve endings of the striatum is associated with microglial activation.', J Pharmacol Exp Ther, 311, pp. 1 - 7, http://dx.doi.org/10.1124/jpet.104.070961

Dudley A; Gilbert RE; Thomas D; Cox A; Price JT; Best J; Jenkins A, 2003, 'STI-571 inhibits in vitro angiogenesis', Biochemical and Biophysical Research Communications, 310, pp. 135 - 142, http://dx.doi.org/10.1016/j.bbrc.2003.08.129

Chin SL; Johnson SA; Quinn J; Mirosavljevic D; Price JT; Dudley AC; Thomas DM, 2003, 'A role for αV integrin subunit in TGF-β-stimulated osteoclastogenesis', Biochemical and Biophysical Research Communications, 307, pp. 1051 - 1058, http://dx.doi.org/10.1016/S0006-291X(03)01294-4

Thomas DM; Yang HS; Alexander K; Hinds PW, 2003, 'Role of the retinoblastoma protein in differentiation and senescence', Cancer Biology and Therapy, 2, pp. 124 - 130, http://dx.doi.org/10.4161/cbt.2.2.235

Dudley A; McKinstry W; Thomas D; Best J; Jenkins A, 2003, 'Removal of endotoxin by reverse phase HPLC abolishes anti-endothelial cell activity of bacterially expressed plasminogen kringle 5', BioTechniques, 35, pp. 724 - 732, http://dx.doi.org/10.2144/03354st02

Cook N; Thomas DM, 2002, 'Retrospective survey of unselected hospital patients with and without cancer comparing outcomes following venous thromboembolism', Internal Medicine Journal, 32, pp. 437 - 444, http://dx.doi.org/10.1046/j.1445-5994.2002.00249.x

Rosenthal MA; Thomas D; Davis I; Toner G; Noordin N; Zalcberg J, 2001, 'Pilot study of oral eniluracil/5-FU in the palliation of hormone-refractory prostate cancer', Prostate Journal, 3, pp. 30 - 35, http://dx.doi.org/10.1046/j.1525-1411.2001.003001030.x

Thomas DM; Carty SA; Piscopo DM; Lee JS; Wang WF; Forrester WC; Hinds PW, 2001, 'The retinoblastoma protein acts as a transcriptional coactivator required for osteogenic differentiation', Molecular Cell, 8, pp. 303 - 316, http://dx.doi.org/10.1016/S1097-2765(01)00327-6

Li HQ; Thomas DB; Berry G; MacLennan R; Shearman R; Jelihovsky T; Booth JC; Molina R; Martinez L; Salas O; Dabancens A; Cuadros A; Aristizabal N; Berry G; Modan B; Ron E; Alfandary E; Mati JG; Kenya P; Kungu A; Gatei D; Cuevas HR; Salazar SB; Palet A; Ontiveros P; Apelo RA; De la Cruz JR; Baens J; Canlas BD; Silpisornkosol S; Pardthaisong T; Charoeniam V; Theetranont C; Boosiri B; Chutivongse S; Virutamasen P; Wongsrichanalai C; Sindhavananda S; Koetsawang S; Rachawat D; Koetsawang A; Riotton G; Christopherson WM; Melnick JL; Adam E; Meirik O; Farley TMM; Holck S, 2000, 'Tubal ligation and risk of cervical cancer', Contraception, 61, pp. 323 - 328, http://dx.doi.org/10.1016/S0010-7824(00)00111-6

Puche RC; Thomas DM; Udagawa N; Hards DK; Quinn JMW; Moseley JM; Findlay DM; Best JD, 1999, 'Letters to the editor (multiple letters).', Bone, 25

Ebeling PR; Thomas DM; Erbas B; Hopper JL; Szer J; Grigg AP, 1999, 'Mechanisms of bone loss following allogeneic and autologous hemopoietic stem cell transplantation', Journal of Bone and Mineral Research, 14, pp. 342 - 350, http://dx.doi.org/10.1359/jbmr.1999.14.3.342

Thomas DM; Ferguson GD; Herschman HR; Elferink LA, 1999, 'Functional and biochemical analysis of the C2 domains of synaptotagmin IV.', Mol Biol Cell, 10, pp. 2285 - 2295, http://dx.doi.org/10.1091/mbc.10.7.2285

Ferguson GD; Thomas DM; Elferink LA; Herschman HR, 1999, 'Synthesis degradation, and subcellular localization of synaptotagmin IV, a neuronal immediate early gene product.', J Neurochem, 72, pp. 1821 - 1831, http://dx.doi.org/10.1046/j.1471-4159.1999.0721821.x

Kuhn DM; Arthur RE; Thomas DM; Elferink LA, 1999, 'Tyrosine hydroxylase is inactivated by catechol-quinones and converted to a redox-cycling quinoprotein: possible relevance to Parkinson's disease.', J Neurochem, 73, pp. 1309 - 1317, http://dx.doi.org/10.1046/j.1471-4159.1999.0731309.x

Thomas DM; Mitchell PLR; Berlangieri SU; Tochon-Danguy H; Knight S; Clarke CP; Scott AM, 1998, 'Correction: Positron emission tomography in assessing response to neoadjuvant chemotherapy for non-small-cell lung cancer (Medical Journal of Australia (1998) 169 (227))', Medical Journal of Australia, 169, pp. 344

Thomas DM; Mitchell PLR; Berlangieri SU; Tochon-Danguy H; Knight S; Clarke CP; Scott AM, 1998, 'Positron emission tomography in assessing response to neoadjuvant chemotherapy for non-small-cell lung cancer (vol 169, pg 227, 1998)', MEDICAL JOURNAL OF AUSTRALIA, 169, pp. 344 - 344, http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000076023200028&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Thomas DM; Udagawa N; Hards DK; Quinn JMW; Moseley JM; Findlay DM; Best JD, 1998, 'Insulin receptor expression in primary and cultured osteoclast-like cells', Bone, 23, pp. 181 - 186, http://dx.doi.org/10.1016/S8756-3282(98)00095-7

Thomas DM; Elferink LA, 1998, 'Functional analysis of the C2A domain of synaptotagmin 1: implications for calcium-regulated secretion.', J Neurosci, 18, pp. 3511 - 3520, http://dx.doi.org/10.1523/JNEUROSCI.18-10-03511.1998

Thomas DM; Zalcberg JR, 1998, '5-Fluorouracil: A pharmacological paradigm in the use of cytotoxics', Clinical and Experimental Pharmacology and Physiology, 25, pp. 887 - 895, http://dx.doi.org/10.1111/j.1440-1681.1998.tb02339.x

Thomas DM; Mitchell PLR; Berlangieri SU; Tochon-Danguy H; Knight S; Clarke CP; Scott AM, 1998, 'Positron emission tomography in assessing response to neoadjuvant chemotherapy for non-small-cell lung cancer [1]', Medical Journal of Australia, 169, pp. 227, http://dx.doi.org/10.5694/j.1326-5377.1998.tb140229.x

Thomas DM; Seymour JF; Szer J; Grigg AP; Basser RL; Green MD; Fox RM; Thomas DM, 1998, 'Progress in management of acute myeloid leukaemia (AML) in Australia since 1980: A single institution retrospective study', Australian and New Zealand Journal of Medicine, 28, pp. 190 - 196, http://dx.doi.org/10.1111/j.1445-5994.1998.tb02968.x

Rosenblatt K; Thomas D, 1997, 'Association between tubal ligation and endometrial cancer.', Int J Cancer, 71, pp. 129 - 130, http://dx.doi.org/10.1002/(sici)1097-0215(19970328)71:1<129::aid-ijc22>3.0.co;2-c

Thomas DM; Ng KW; Best JD, 1997, 'Insulin and bone: A clinical and scientific review', Endocrinology and Metabolism, Supplement, 4, pp. 5 - 17

Thomas DM; Seymour JF; Griffiths JD; Szer J; Grigg AP, 1997, 'Prolonged disease-free survival with specific re-induction therapy in acute myeloid leukaemia relapsing following bone marrow transplantation', Australian and New Zealand Journal of Medicine, 27, pp. 712 - 713, http://dx.doi.org/10.1111/j.1445-5994.1997.tb01009.x

Rosenblatt KA; Thomas DB; Berry G; MacLennan R; Shearman R; Jelihovsky T; Booth JC; Molina R; Martinez L; Salas O; Dabancens A; Zhiheng C; Yun T; Wei HY; Modan B; Ron E; Alfandary E; Rodriguez Cuevas H; Benavides Salazar S; Palet A; Ontiveros P; Apelo RA; De La Cruz JR; Baens J; Javier B; Silpisornkosol S; Pardthaisong T; Martin N; Theetranont C; Boosiri B; Chutivongse S; Virutamasen P; Wongsrichanalai C; Jimakorn P; Koetsawang S; Rachawat D; Chantarakul N; Langley FA; Noonan EA; Hoick S; Farley T; Meirik O, 1996, 'Intrauterine devices and endometrial cancer', Contraception, 54, pp. 329 - 332, http://dx.doi.org/10.1016/S0010-7824(96)00199-0

Thomas DM; Maher F; Rogers SD; Best JD, 1996, 'Expression and regulation by insulin of Glut 3 in UMR 106-01, a clonal rat osteosarcoma cell line', Biochemical and Biophysical Research Communications, 218, pp. 789 - 793, http://dx.doi.org/10.1006/bbrc.1996.0140

Thomas DM; Rogers SD; Ng KW; Best JD, 1996, 'Dexamethasone modulates insulin receptor expression and subcellular distribution of the glucose transporter GLUT 1 in UMR 106-01, a clonal osteogenic sarcoma cell line', Journal of Molecular Endocrinology, 17, pp. 7 - 17, http://dx.doi.org/10.1677/jme.0.0170007

Thomas DM; Hards DK; Rogers SD; Ng KW; Best JD, 1996, 'Insulin receptor expression in bone', Journal of Bone and Mineral Research, 11, pp. 1312 - 1320, http://dx.doi.org/10.1002/jbmr.5650110916

Thomas DM; Rogers SD; Sleeman MW; Pasquini GM; Bringhurst FR; Ng KW; Zajac JD; Best JD, 1995, 'Modulation of glucose transport by parathyroid hormone and insulin in UMR 106-01, a clonal rat osteogenic sarcoma cell line', Journal of Molecular Endocrinology, 14, pp. 263 - 275, http://dx.doi.org/10.1677/jme.0.0140263

Prentice RL; Thomas D, 1993, 'Methodologic research needs in environmental epidemiology: data analysis.', Environ Health Perspect, 101 Suppl 4, pp. 39 - 48, http://dx.doi.org/10.1289/ehp.93101s439

Lazovich D, 1992, 'Breast-Conserving Surgery and Radiation Therapy: Are They Underused?-Reply', JAMA: The Journal of the American Medical Association, 268, pp. 869 - 869, http://dx.doi.org/10.1001/jama.1992.03490070047024

Silpisornkosol S; Pardthaisong T; Sahapong V; Theetranont C; Boosiri B; Chutivongse S; Virutamasen P; Wongsrchanalai C; Sindhvananda S; Koetsawang S; Rachawat D; Koetsawang A; Langley FA; Thomas Study Coordinator DB; Ray RM; Noonan EA; Stanford JL; Rosenblatt KA; Holck S; Farley TMM; Thomas DB, 1991, 'Depot‐medroxyprogesterone acetate (dmpa) and risk of edometrial cancer', International Journal of Cancer, 49, pp. 186 - 190, http://dx.doi.org/10.1002/ijc.2910490207

Witherspoon RP; Fisher LD; Schoch G; Martin P; Sullivan KM; Sanders J; Deeg HJ; Doney K; Thomas D; Storb R, 1989, 'Secondary cancers after bone marrow transplantation for leukemia or aplastic anemia.', N Engl J Med, 321, pp. 784 - 789, http://dx.doi.org/10.1056/NEJM198909213211203

Severson RK; Stevens RG; Davis S; Thomas D; Heuser L; Sever LE, 1989, 'THE AUTHORS REPLY', American Journal of Epidemiology, 130, pp. 425 - 427, http://dx.doi.org/10.1093/oxfordjournals.aje.a115352

Back to profile page